Viscosupplementation Market to Reach USD 15.26 Billion by 2034, Growing at a 10.1% CAGR

𝐕𝐢𝐬𝐜𝐨𝐬𝐮𝐩𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐒𝐢𝐳𝐞 𝐑𝐞𝐯𝐞𝐧𝐮𝐞, 𝐎𝐮𝐭𝐥𝐨𝐨𝐤, 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰, 𝐚𝐧𝐝 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬. 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐯𝐢𝐬𝐜𝐨𝐬𝐮𝐩𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 𝐔𝐒𝐃 𝟓.𝟖𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟒 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐞𝐝𝐢𝐜𝐭𝐞𝐝 𝐭𝐨 𝐞𝐱𝐩𝐚𝐧𝐝 𝐭𝐨 𝐔𝐒𝐃 𝟏𝟓.𝟐𝟔 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟒, 𝐰𝐢𝐭𝐡 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟎.𝟏% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟓 𝐭𝐨 𝟐𝟎𝟑𝟒.

𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐜𝐨𝐩𝐞:
This comprehensive study provides an accurate overview of the worldwide viscosupplementation industry. Comprehensive analyses of sales volume, price, revenue, market share, and important companies are included. The market is further divided into segments by product, end-use, and region in the study, which offers a comprehensive picture of the state of the market.

Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market/request-for-sample

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐞𝐟𝐢𝐧𝐢𝐭𝐢𝐨𝐧:
In viscosupplementation, the healthcare donor injects hyaluronic acid into the joints. This dense fluid may assist in easing pain and swelling in the knee. The bones that constitute the joints usually have a cap of cartilage on their ends. This cartilage assists in ascertaining that the bones operate seamlessly against each other. This cartilage has a liquid coating that comprises hyaluronic acid.

𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐓𝐫𝐞𝐧𝐝𝐬:
• Knee OA is one of the most customary configurations of arthritis, causing notable pain, decreased movements, and a degenerated standard of life for impacted persons. The knee is the most impacted joint, with 365 million cases, followed by the hip and hand.
• The existence of age-connected illnesses, such as knee osteoarthritis (OA), is rising as the worldwide population matures. Elderly people are more susceptible to joint debasement, causing an elevated existence of knee OA, which is causing detrimental pain and impairment in this community.

𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬:
The market is excessively aggressive, with both worldwide and domestic players struggling to brace up their positions through inventions, associations, and tactical augmentation. Here are the top companies in the viscosupplementation market:

• Anika Therapeutics, Inc.
• DePuy Synthes
• F.Hoffmann-La Roche Ltd.
• Ferring Pharmaceuticals B.V.
• Fidia Farmaceutici S.p.A
• LG Life Sciences Ltd.
• Lifecore Biomedical
• Sanofi
• Seikagaku Corp.
• Smith & Nephew PLC

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market/request-for-discount-pricing

𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐨𝐟 𝐕𝐢𝐬𝐜𝐨𝐬𝐮𝐩𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭
• In terms of product, in 2024, the three injection segment accounted for the largest market share due to its established efficacy, widespread availability, and preference among healthcare providers for managing knee osteoarthritis.

• Based on end use, the orthopedic clinics/ASCs segment is expected to witness the fastest growth during the forecast period due to increasing patient preference for specialized, cost-effective, and minimally invasive treatments offered in these settings.

• In 2024, Asia Pacific accounted for the largest share of the viscosupplementation market due to the region's large aging population and increasing prevalence of knee osteoarthritis.

• The Europe viscosupplementation market is expected to witness the fastest CAGR during the forecast period due to increasing demand for advanced osteoarthritis treatments.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤
By Product Outlook (Revenue - USD Billion, 2020-2034)
• Three Injection
• Five Injection
• Single Injection

By End Use Outlook (Revenue - USD Billion, 2020-2034)
• Orthopedic Clinics/ASCs
• Hospitals

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market

𝐂𝐨𝐮𝐧𝐭𝐫𝐲-𝐖𝐢𝐬𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬
According to regional research, Asia Pacific dominated the market. The region's growth is aided by an escalating aging population, the growing existence of knee osteoarthritis, and the growing consciousness of nonsurgical cure alternatives. Also, Europe is anticipated to emerge as the fastest-growing region in the viscosupplementation market.

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
Postpartum Products Market
https://www.polarismarketresearch.com/industry-analysis/postpartum-products-market

Medical Alert Systems Market
https://www.polarismarketresearch.com/industry-analysis/medical-alert-systems-market

Artificial Tendons and Ligaments Market
https://www.polarismarketresearch.com/industry-analysis/artificial-tendons-and-ligaments-market

Targeted Protein Degradation Market
https://www.polarismarketresearch.com/industry-analysis/targeted-protein-degradation-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.